Kenneth C Frazier insider trades: Eikon Therapeutics (EIKN) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kenneth reports to the SEC
Open-market buys and sales
35 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | EIKN | ↑ Buy | 111,111 | $18.00 | $2.0M | Direct | Feb 6, 2026 (2d) |
| Nov 7, 2022 | MRK | ↓ Sell | 235,769 | $99.55 | $23.5M | Direct | Nov 8, 2022 (1d) |
| Nov 4, 2022 | MRK | ↓ Sell | 470,000 | $98.66 | $46.4M | Direct | Nov 7, 2022 (3d) |
| Nov 2, 2022 | MRK | ↓ Sell | 600,000 | $99.86 | $59.9M | Direct | Nov 3, 2022 (1d) |
| Oct 31, 2022 | MRK | ↓ Sell | 867,084 | $100.44 | $87.1M | Direct | Nov 1, 2022 (1d) |
| Nov 9, 2021 | MRK | ↓ Sell | 663,881 | $82.26 | $54.6M | Direct | Nov 10, 2021 (1d) |
| Nov 9, 2020 | MRK | ↓ Sell | 280,000 | $81.42 | $22.8M | Direct | Nov 12, 2020 (3d) |
| Mar 20, 2019 | MRK | ↓ Sell | 192,736 | $82.05 | $15.8M | Direct | Mar 20, 2019 (0d) |
| Mar 13, 2019 | MRK | ↓ Sell | 18,725 | $82.00 | $1.5M | Direct | Mar 14, 2019 (1d) |
| Mar 5, 2019 | MRK | ↓ Sell | 20,105 | $82.00 | $1.6M | Direct | Mar 6, 2019 (1d) |
| Feb 22, 2019 | MRK | ↓ Sell | 95,953 | $80.01 | $7.7M | Direct | Feb 22, 2019 (0d) |
| Feb 19, 2019 | MRK | ↓ Sell | 135,613 | $80.03 | $10.9M | Direct | Feb 19, 2019 (0d) |
| Feb 5, 2019 | MRK | ↓ Sell | 231,566 | $78.08 | $18.1M | Direct | Feb 6, 2019 (1d) |
| Oct 2, 2018 | MRK | ↓ Sell | 279,850 | $72.07 | $20.2M | Direct | Oct 3, 2018 (1d) |
| Sep 18, 2018 | MRK | ↓ Sell | 279,851 | $70.08 | $19.6M | Direct | Sep 19, 2018 (1d) |
| Jul 31, 2018 | MRK | ↓ Sell | 228,091 | $65.00 | $14.8M | Direct | Aug 1, 2018 (1d) |
| Nov 10, 2016 | MRK | ↓ Sell | 140,000 | $65.03 | $9.1M | Direct | Nov 10, 2016 (0d) |
| Aug 5, 2016 | MRK | ↓ Sell | 392,000 | $61.81 | $24.2M | Direct | Aug 5, 2016 (0d) |
| Jul 5, 2016 | MRK | ↓ Sell | 60,000 | $58.00 | $3.5M | Direct | Jul 5, 2016 (0d) |
| Apr 14, 2016 | MRK | ↓ Sell | 131,040 | $56.11 | $7.4M | Direct | Apr 14, 2016 (0d) |
| Oct 29, 2015 | MRK | ↓ Sell | 18,666 | $54.69 | $1.0M | Direct | Oct 30, 2015 (1d) |
| Feb 18, 2015 | MRK | ↓ Sell | 5,164 | $58.67 | $303K | Direct | Feb 18, 2015 (0d) |
| Jan 9, 2015 | MRK | ↓ Sell | 8,840 | $62.47 | $552K | Direct | Jan 9, 2015 (0d) |
| Dec 10, 2014 | MRK | ↓ Sell | 9,846 | $60.00 | $591K | Direct | Dec 10, 2014 (0d) |
| Nov 10, 2014 | MRK | ↓ Sell | 10,000 | $57.98 | $580K | Direct | Nov 10, 2014 (0d) |
| Oct 10, 2014 | MRK | ↓ Sell | 9,895 | $59.73 | $591K | Direct | Oct 14, 2014 (4d) |
| Sep 10, 2014 | MRK | ↓ Sell | 9,814 | $60.48 | $594K | Direct | Sep 10, 2014 (0d) |
| Aug 11, 2014 | MRK | ↓ Sell | 10,058 | $57.00 | $573K | Direct | Aug 12, 2014 (1d) |
| Jul 10, 2014 | MRK | ↓ Sell | 9,987 | $58.03 | $580K | Direct | Jul 10, 2014 (0d) |
| Jun 10, 2014 | MRK | ↓ Sell | 9,985 | $58.06 | $580K | Direct | Jun 11, 2014 (1d) |
| May 9, 2014 | MRK | ↓ Sell | 10,220 | $55.00 | $562K | Direct | May 13, 2014 (4d) |
| Apr 10, 2014 | MRK | ↓ Sell | 10,047 | $57.24 | $575K | Direct | Apr 11, 2014 (1d) |
| Feb 11, 2014 | MRK | ↓ Sell | 41,520 | $54.52 | $2.3M | Direct | Feb 11, 2014 (0d) |
| Aug 15, 2011 | MRK | ↑ Buy | 32,000 | $31.78 | $1.0M | Direct | Aug 15, 2011 (0d) |
| Feb 15, 2006 | (MRK) | ↓ Sell | 63,299 | $35.00 | $2.2M | Direct | Feb 17, 2006 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other EIKN insiders
Open-market trades in the last 12 months
About Kenneth C Frazier's insider trades
Kenneth C Frazier is an insider at Eikon Therapeutics (EIKN). Since Feb 15, 2006, Kenneth has reported 2 open-market purchases worth $3.0M and 33 sales worth $460.2M on SEC Form 4. In the last 12 months: 1 buy ($2.0M).
Their filings also include grants and awards (50 filings), option exercises (39 filings), shares withheld for taxes (8 filings), gifts (7 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EIKN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.